Type 1 diabetes as a relapsing-remitting disease?

被引：191
作者：
von Herrath, Matthias
Sanda, Srinath
Herold, Kevan
机构：
[1] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA
[2] Benaroya Res Inst, Seattle, WA 98101 USA
[3] Yale Univ, Sch Med, New Haven, CT 06509 USA
来源：
NATURE REVIEWS IMMUNOLOGY | 2007年 / 7卷 / 12期
关键词：
D O I：
10.1038/nri2192
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Chronic immunological processes that underlie persistent viral infections and autoimmune disorders such as multiple sclerosis can be relapsing - remitting in nature. The progressive loss of beta-cell mass during the development of autoimmune type 1 diabetes ( T1D) can also be non - linear, but the exact nature and kinetics of the immunological processes that govern T1D are not known. Here, we propose that the immunological process that is at the root of T1D is relapsing remitting in nature and discuss the unresolved controversies and therapeutic implications of this hypothesis.
引用
收藏
页码：988 / 994
页数：7
相关论文
共 53 条
[1]   Natural history of type 1 diabetes [J].
Achenbach, P ;
Bonifacio, E ;
Koczwara, K ;
Ziegler, AG .
DIABETES, 2005, 54 :S25-S31
[2]   Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes [J].
Agardh, CD ;
Cilio, CM ;
Lethagen, Å ;
Lynch, K ;
Leslie, RDG ;
Palmér, M ;
Harris, RA ;
Robertson, JA ;
Lernmark, Å .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2005, 19 (04) :238-246
[3]   Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health [J].
Arif, S ;
Tree, TI ;
Astill, TP ;
Tremble, JM ;
Bishop, AJ ;
Dayan, CM ;
Roep, BO ;
Peakman, M .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (03) :451-463
[4]   TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes [J].
Belghith, M ;
Bluestone, JA ;
Barriot, S ;
Mégret, J ;
Bach, JF ;
Chatenoud, L .
NATURE MEDICINE, 2003, 9 (09) :1202-1208
[5]  
Böber E, 2001, J PEDIATR ENDOCR MET, V14, P435
[6]  
Bonifacio E, 1999, J IMMUNOL, V163, P525
[7]   Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs [J].
Bresson, D ;
Togher, L ;
Rodrigo, E ;
Chen, YL ;
Bluestone, JA ;
Herold, KC ;
von Herrath, M .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (05) :1371-1381
[8]   ESSENTIAL ROLE FOR INTERFERON-GAMMA AND INTERLEUKIN-6 IN AUTOIMMUNE INSULIN-DEPENDENT DIABETES IN NOD/WEHI MICE [J].
CAMPBELL, IL ;
KAY, TWH ;
OXBROW, L ;
HARRISON, LC .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :739-742
[9]   Redefining the clinical remission period in children with type 1 diabetes [J].
Chase, HP ;
MacKenzie, TA ;
Burdick, J ;
Fiallo-Scharer, R ;
Walravens, P ;
Klingensmith, G ;
Rewers, M .
PEDIATRIC DIABETES, 2004, 5 (01) :16-19
[10]   ANTI-CD3 ANTIBODY INDUCES LONG-TERM REMISSION OF OVERT AUTOIMMUNITY IN NONOBESE DIABETIC MICE [J].
CHATENOUD, L ;
THERVET, E ;
PRIMO, J ;
BACH, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) :123-127
123456